356 findings · Molecular
- MolecularStrong
Interleukin 6 and 8 (IL-6 and IL-8), leukocyte-inducing factor, and connective tissue growth factor (CTGF) mRNA levels increased approximately 10-fold after a single exercise bout.
Exercise significantly increases the expression of certain myokines, which may influence muscle physiology.
Supports Sourced - MolecularStrong
Myostatin levels decreased after a single exercise bout.
Exercise may reduce myostatin levels, which could be beneficial for muscle growth.
Supports Sourced - MolecularStrong
Myokine expressions in myotubes from sedentary donors for CTGF and myostatin decreased, whereas IL-6 and IL-8 increased after PFI treatment.
Sedentary individuals may experience different myokine responses to pharmacological treatments mimicking exercise.
Supports Sourced - MolecularStrong
Hyperglycemia reduces free fatty acid (FFA) turnover by 30% (29 +/- 2 vs. 20 +/- 3 mumol.kg fat mass-1.min-1, P less than 0.05).
Practitioners should consider that elevated glucose levels can significantly impact lipid metabolism.
Supports Sourced - MolecularStrong
Glycerol turnover, representing lipolysis, is also reduced by hyperglycemia (9.4 +/- 0.9 vs. 6.2 +/- 0.7 mumol.kg fat mass-1.min-1, P less than 0.05).
Elevated glucose levels can inhibit lipolysis, affecting fat metabolism.
Supports Sourced - MolecularStrong
Glucose regulates lipid metabolism independently of changes in hormone concentrations.
Practitioners should recognize that glucose levels can influence lipid metabolism without hormonal involvement.
Supports Sourced - MolecularStrong
Endurance-trained males (ETM) demonstrated lower alpha1, alpha3, beta2, and beta3 mRNA expression by 74%, 62%, 70%, and 82%, respectively, than recreationally active males (RAM).
Endurance training may lead to significant differences in specific Na+,K+-pump mRNA expressions compared to recreational activity.
Supports Sourced - MolecularStrong
ω-3-PL/FFA was well tolerated with a safety profile similar to that of placebo.
Practitioners can confidently recommend ω-3-PL/FFA as a safe option for patients.
Supports Sourced - MolecularStrong
Higher levels of circulating behenic acid are associated with a 15% lower risk of unhealthy aging events.
Practitioners may consider monitoring behenic acid levels as a potential marker for healthy aging.
Supports Sourced - MolecularStrong
Higher levels of circulating lignoceric acid are associated with a 16% lower risk of unhealthy aging events.
Practitioners may consider monitoring lignoceric acid levels as a potential marker for healthy aging.
Supports Sourced - MolecularStrong
The study highlights the need to explore determinants of circulating very-long-chain saturated fatty acids (VLSFAs) for promoting healthy aging.
Practitioners and researchers should consider investigating VLSFAs further to enhance strategies for healthy aging.
Supports Sourced - MolecularStrong
Stable isotope tracers have significantly advanced the understanding of muscle protein turnover.
Utilizing stable isotope tracers can enhance research and understanding of muscle protein metabolism.
Supports Sourced - MolecularStrong
Calorie restriction (CR) resulted in 88 differentially regulated genes compared to 39 in calorie restriction with exercise (CREX).
Practitioners should note that calorie restriction alone may have a more significant impact on gene regulation than combining it with exercise.
Supports Sourced - MolecularStrong
Calorie restriction specifically downregulated chemokine signaling-related pathways.
Understanding the downregulation of chemokine pathways may help in developing targeted interventions for health benefits of calorie restriction.
Supports Sourced - MolecularStrong
The study of exercise as a preventative or therapeutic treatment is increasingly interdisciplinary and impactful.
Researchers and practitioners should collaborate across disciplines to enhance exercise interventions.
Supports Sourced - MolecularStrong
MYOD1, MYF5, and MYF6 mean methylation was reduced after 4 and 8 hours in response to all exercise protocols.
Resistance, high-intensity interval, and concurrent exercise can effectively reduce DNA methylation in myogenic regulatory factors.
Supports Sourced - MolecularStrong
Changes in DNA methylation and mRNA expression were largely confined to the late (4-8 h) recovery period.
Recovery periods after exercise are critical for observing changes in muscle regulatory factors.
Supports Sourced - MolecularStrong
High-circulating lipid availability results in lower peak aminoacidemia following protein ingestion.
Understanding the impact of lipid levels on amino acid availability can inform dietary strategies.
Supports Sourced - MolecularStrong
Semaglutide has a higher pooled reporting odds ratio (ROR) for gastrointestinal adverse drug reactions (GADRs) compared to liraglutide (5.53 vs 3.95).
Clinicians should consider the higher gastrointestinal risk associated with semaglutide when prescribing.
Supports Sourced - MolecularStrong
Semaglutide has a later pooled time-to-onset median of GADRs compared to liraglutide (7 days vs 4 days).
Healthcare providers should be aware of the delayed onset of gastrointestinal issues with semaglutide.
Supports Sourced - MolecularStrong
DEPTOR is identified as a critical mechanistic candidate for disuse-driven MPS suppression.
Targeting DEPTOR may offer a therapeutic approach to counteract muscle loss during periods of disuse.
Supports Sourced - MolecularStrong
Metabolic dysregulation is linked to ectopic fat deposition and alterations in immune cell populations in adipose tissue among PWH.
Understanding these links can help in developing targeted interventions for obesity in PWH.
Supports Sourced - MolecularStrong
Post-exercise changes in proteins reflective of protein synthesis were similar between groups, though some mRNA exhibited exercise order-dependent responses.
Understanding the molecular responses can help tailor exercise programs for optimal protein synthesis.
Qualifies Sourced - MolecularStrong
There is a surge of interest in unimolecular peptide hormone-based polypharmacy for obesity management.
Practitioners should stay informed about developments in peptide hormone therapies for obesity.
Supports Sourced